Interferon-associated retinopathy - A case report

Klinische Monatsblatter fur Augenheilkunde

Volumn 224, Issue 4, 2007, Pages 350-352

  Mantel, Irmela ^a   Konstantinidis, L ^a   Zografos, L ^a  

^a JULES GONIN EYE HOSPITAL   (Switzerland)

Author keywords

Chronic hepatitis C; Interferon associated; Occular side effects; Retinopathy

Indexed keywords

ALPHA INTERFERON;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; GLUCOSE INTOLERANCE; HEPATITIS C; HUMAN; HYPERTENSION; MICROANEURYSM; MICROCYTIC ANEMIA; PIGMENT EPITHELIUM; RETINA DETACHMENT; RETINOPATHY; RISK FACTOR; TREATMENT OUTCOME;

AGED; ANEURYSM; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; RETINAL ARTERY OCCLUSION; RETINITIS PIGMENTOSA;

EID: 34248351112     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-962837     Document Type: Article

References (13)

1. Andrade RJ, Gonzalez FJ, Vazquez L et al. Vascular ophthalmological side effects associated with antiviral therapy for chronic hepatitis C are related to vascular endothelial growth factor levels. Antivir Ther 2006; 11: 491-498
2. d'Alteroche L, Majzoub S, Lecuyer AI et al. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis. J Hepatol 2006; 44: 56-61
3. de Venecia G, Jampol LM. The eye in accelerated hypertension. II. Localized serous detachments of the retina in patients. Arch Ophthalmol 1984; 102: 68-73
4. Guyer DR, Tiedeman J, Yannuzzi LA et al. Interferon-associated retinopathy. Arch Ophthalmol 1993; 111: 350-356
5. Hoerauf H, Schmidt-Erfurth U, Asiyo-Vogel M et al. Combined choroidal and retinal ischemia during interferon therapy: indocyanine green angiographic and microperimetric findings. Arch Ophthalmol 2000; 118: 580-582
6. Morse PH. Elschnig's spots and hypertensive choroidopathy. Am J Ophthalmol 1968; 66: 844-852
7. Nicolo M, Artioli S, La Mattina GC et al. Branch retinal artery occlusion combined with branch retinal vein occlusion in a patient with hepatitis C treated with interferon and ribavirin. Eur J Ophthalmol 2005; 15: 811-814
8. Okuse C, Yotsuyanagi H, Nagase Y et al. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol 2006; 12: 3756-3759
9. Sandner D, Pillunat LE. Reversible perimacular retinopathy by long-time interferon alpha therapy. Klin Monatsbl Augenheilkd 2004; 221: 63-66
10. Schmidt S, Pleyer U. Interferon alpha-associated retinopathy in patients with chronic hepatitis C. Klin Monatsbl Augenheilkd 2005; 222: 915-918
11. Schulman JA, Liang C, Kooragayala LM et al. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmology 2003; 110: 437-442
12. Shimura M, Saito T, Yasuda K et al. Clinical course of macular edema in two cases of interferon-associated retinopathy observed by optical coherence tomography. Jpn J Ophthalmol 2005; 49: 231-234
13. Stoffelns BM. Interferon causes ischemic ocular diseases - case studies and review of the literature. Klin Monatsbl Augenheilkd 2006; 223: 367-371